EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 3.0

Enhanced Bioavailability of a Thionated IMiD Derivative Nanosuspension for Parkinson’s Disease Targeting α-Synuclein

Luca Casula iD, Maria Francesca Palmas, Maria Cristina Cardia, Donatella Valenti, Elena Pini iD, Michela Etzi, Salvatore Marceddu iD, Chiara Sinico, David Tweedie, Nigel H Greig, Dong Seok Kim, Anna Rosa Carta und 1 weitere

International Journal of Nanomedicine · 2025

DOI: 10.2147/ijn.s543652 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Nanomedicine, 2025. Verfasst von Luca Casula und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Life and Environmental Sciences, University of Cagliari, Cagliari, Italy. Hauptthemen laut MEDLINE: alpha-Synuclein, Nanoparticles, Parkinson Disease, Thalidomide. Die Arbeit nennt 63 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

alpha-SynucleinNanoparticlesParkinson DiseaseThalidomideBiological AvailabilityAnimalsRatsSolubilityMaleParticle SizeSuspensionsRats, Sprague-DawleyNeuroprotective AgentsHumans

Stichwörter der Autor:innen

3-MonothiopomalidomideIMiDsParkinson’s diseasebrain deliveryimmunomodulatory imide drugsnanocrystalspomalidomide

Substanzen

alpha-SynucleinThalidomideSuspensionsNeuroprotective Agents

Autor:innen und Institutionen

  • Department of Life and Environmental Sciences, University of Cagliari, Cagliari, Italy.
  • Department of Biomedical Sciences, University of Cagliari, Cagliari, Italy.
  • Departmentof Pharmaceutical Sciences, University of Milan, Milan, Italy.
  • Institute of Sciences of Food Production (ISPA-CNR), Baldinca (Sassari), Italy.
  • Drug Design & Development Section, Translational Gerontology Branch, Intramural Research Program, National Institute on Aging, National Institutes of Health, Baltimore, MD, USA.
  • AevisBio, Inc., Gaithersburg, MD, USA.

ORCID-Profile: Luca Casula, Elena Pini, Salvatore Marceddu

Zitieren

APA

Casula, L., Palmas, M. F., Cardia, M. C., Valenti, D., Pini, E., Etzi, M., Marceddu, S., Sinico, C., Tweedie, D., Greig, N. H., Kim, D. S., Carta, A. R., & Lai, F. (2025). Enhanced Bioavailability of a Thionated IMiD Derivative Nanosuspension for Parkinson’s Disease Targeting α-Synuclein. International Journal of Nanomedicine. https://doi.org/10.2147/ijn.s543652

Vancouver

Casula L, Palmas MF, Cardia MC, Valenti D, Pini E, Etzi M, et al. Enhanced Bioavailability of a Thionated IMiD Derivative Nanosuspension for Parkinson’s Disease Targeting α-Synuclein. International Journal of Nanomedicine. 2025. doi:10.2147/ijn.s543652

BibTeX
@article{Casula2025,
  author = {Casula, Luca and Palmas, Maria Francesca and Cardia, Maria Cristina and Valenti, Donatella and Pini, Elena and Etzi, Michela and Marceddu, Salvatore and Sinico, Chiara and Tweedie, David and Greig, Nigel H and Kim, Dong Seok and Carta, Anna Rosa and Lai, Francesco},
  title = {Enhanced Bioavailability of a Thionated IMiD Derivative Nanosuspension for Parkinson’s Disease Targeting α-Synuclein},
  journal = {International Journal of Nanomedicine},
  year = {2025},
  doi = {10.2147/ijn.s543652}
}
Kostenlos starten →